Skip to main content

Get the latest public health information from CDC

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • English
  • Español (Spanish)

Language:

  • English
  • Español

clinicalinfo.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Guidance for Covid-19 and People with HIV is now available.

See Guidance 

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.
Guidelines 

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs. Drugs 

Glossary

Medical dictionary of HIV-related terms.
Glossary 

Resources

HIV-related resources from the National Institutes of Health.
Resources 

Mobile Application

Mobile App Information 
Our website, Clinicalinfo.HIV.gov, is now optimized for mobile browsing. Therefore, the Clinicalinfo mobile application will sunset on December 30, 2022.


 

 

Interactions between Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors

  • Read more about Interactions between Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors

Drug Interactions between CCR5 Antagonist and Other Drugs

  • Read more about Drug Interactions between CCR5 Antagonist and Other Drugs

Drug Interactions between Integrase Inhibitors and Other Drugs

  • Read more about Drug Interactions between Integrase Inhibitors and Other Drugs

Drug Interactions between Nucleoside Reverse Transcriptase Inhibitors and Other Drugs (Including Antiretroviral Agents)

  • Read more about Drug Interactions between Nucleoside Reverse Transcriptase Inhibitors and Other Drugs (Including Antiretroviral Agents)

Drug Interactions between Non-Nucleoside Reverse Transcriptase Inhibitors and Other Drugs

  • Read more about Drug Interactions between Non-Nucleoside Reverse Transcriptase Inhibitors and Other Drugs

Drug Interactions between Protease Inhibitors and Other Drugs

  • Read more about Drug Interactions between Protease Inhibitors and Other Drugs

Overview

  • Read more about Overview

Cost Considerations and Antiretroviral Therapy

  • Read more about Cost Considerations and Antiretroviral Therapy

Adverse Effects of Antiretroviral Agents

  • Read more about Adverse Effects of Antiretroviral Agents

Adherence to the Continuum of Care

  • Read more about Adherence to the Continuum of Care

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Current page 14
  • Page 15
  • Page 16
  • Next page Next ›
  • Last page Last »

CONNECT WITH US

Facebook
Twitter
Instagram
Email Updates

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.